Work

699 Safety Outcomes and Concomitant Medication Changes in Patients With Inflammatory Bowel Disease Being Treated With Rbx2660 for Recurrent Clostridioides Difficile Infection

Year: 2023

Type: article

Source: Gastroenterology

DOI: 10.1016/s0016-5085(23)01306-9

Authors: Jessica R. Allegretti, Paul Feuerstadt, Whitfield L. Knapple, Robert Orenstein, Philippe Pinton, Jonas Pettersson, Bryan Fuchs, Samson Ng, Victoria Pokhilko, Alexander Sheh, Sahil Khanna

Language: English

Topic: Clostridium difficile and Clostridium perfringens research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4383388289

FWCI:

Cites:

Cited by:

Related to: 10